Skip to main content
Erschienen in: Journal of Cardiothoracic Surgery 1/2010

Open Access 01.12.2010 | Case report

Papillary fibroelastoma of the aortic valve - a case report and literature review

verfasst von: Neerod K Jha, Michael Khouri, Donogh M Murphy, Alessandro Salustri, Javed A Khan, Moataz A Saleh, Friederike Von Canal, Norbert Augustin

Erschienen in: Journal of Cardiothoracic Surgery | Ausgabe 1/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

The prevalence of primary cardiac tumour ranges from 0.0017-0.28% and papillary fibroelastoma is rare but not uncommon benign cardiac neoplasm. Currently, with the advent of higher-resolution imaging technology especially transoesophageal echocardiography such cases being recognized frequently. The clinical presentation of these tumours varies from asymptomatic to severe ischaemic or embolic complications. We herein, present a 50-year-old female patient with a papillary fibroelastoma of the aortic valve arising from the endocardium of the right coronary cusp very close to the commissure between the right and non-coronary cusps. The patient presented with angina-like chest pain and was investigated using echocardiography and CT angiographic modalities in addition to the usual investigations. The differential diagnosis considered was a thrombus, myxoma, Lambl's excrescence and infective vegetation. The surgical management included a prompt resection of the tumour on cardiopulmonary bypass avoiding injury to the aortic valve. The patient recovered well. A review of the literature suggests that the cardiac papillary fibroelastoma is a rare but potentially treatable cause of embolic stroke and other fatal complications, therefore, a strong suspicion; appropriate use of imaging modality, preoperative anticoagulation and urgent surgical resection is warranted. Also, possibility of this diagnosis should be kept in mind while managing cardiac or valvular tumours.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1749-8090-5-84) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

All authors have contributed in case management, manuscript preparation and image acquisition.

Introduction

Although the prevalence of primary cardiac tumors ranges from 0.0017-0.28%, the papillary fibroelastomas (PFE) are second most common benign neoplasm of the cardiac valves after myxomas [13]. Currently, with the advent of higher- resolution imaging technology such cases are diagnosed more frequently [114]. We herein, present a 50-year-old female patient with PFE arising from the endocardium of the right coronary cusp of the aortic valve that presented with recurrent angina-like chest pain and successfully managed with valve-sparing resection of the tumor on cardiopulmonary bypass. This report not only highlights typical presentation of this tumor but also reminds us to keep this possibility in patients who present with mass in the ascending aorta, aortic valve or those associated with angina-like or neurological symptoms.

Case report

A 50-year-old female presented to our hospital for evaluation of chest pain. She had history of recurrent, vague, central chest pain with radiation to inter-scapular area. The pain was compressive and mild in nature and was not associated with effort. The clinical examination and routine blood laboratory investigations were unremarkable. The electrocardiography including stress test was also inconclusive. The chest x ray was normal. A 2-D and transoesophageal echocardiography (TEE) revealed presence of an echodense supra valvular, pedunculated, spherical mass of 1.2 × 1 cm in size about 1.2 cm above the aortic annulus (Figure 1). This supra valvular echogenic mass was found to be moving and displaced during each phase of the cardiac cycle and it was very close to the orifice of the right coronary artery (RCA) (Figure 2 and 3). However, the aortic valve and other cardiac structures were normal. There was no regurgitation of the aortic valve. A contrast-enhanced computerized tomography scan of the chest confirmed the presence of a mildly ill-defined, non-enhancing, hypodense nodular lesion of approximate size 1.0 × 0.8 × 0.7 cm in the aortic root, just adjacent to the origin of right coronary artery (Figure 4). Based upon the findings as above, a differential diagnosis was made which included, thrombus, myxoma, fibroelastoma and inflammatory mass.
In view of the possibility of embolism and unknown nature of the pathology, the patient was taken for urgent surgical resection under standard cardiopulmonary bypass at systemic hypothermia (32 degree Celsius) and systemic heparinisation. The ascending aortic and right atrial cannulation was done before institution of cardiopulmonary bypass. The aortic cross clamp was applied and heart was arrested using antegrade blood cardioplegia via the root. Subsequently, a transverse aortotomy was performed proximal to the aortic root. On exploration a 1 × 1 cm pedunculated tumor mass was found to be attached to the right coronary cusp very close to the commissure between the right and non-coronary cusp of the aortic valve. The tumor mass was firm, glistening, friable and looked filamentous on gross examination (Figure 5). The aortic valve was tri-leaflet and structurally and functionally found to be normal. A complete resection of the tumor was achieved which was confirmed by postoperative TEE (Figure 6). The aortic valve was found to be competent and functionally well without any residual defect or perforation after the procedure. The patient had an uneventful weaning from the cardiopulmonary bypass and recovered well in the immediate post operative period.
Histopathology examination of the resected tumor revealed a papillary proliferation including few fibroblasts, collagen and elastic fibers, covered with hyperplastic endothelial cells. These features confirmed the diagnosis of papillary fibroelastoma (Figure 7). The postoperative course was uneventful and the patient was discharged in a satisfactory condition on 7th day.

Discussion

Cardiac papillary fibroelastomas are classified as primary benign endocardial tumours arising from the normal component of the endocardium like fibrous tissue, elastic fibers or smooth muscle cells. Characteristically they have a short pedicle and multiple papillary fronds similar to a sea anemone [1]. They often (85%) originate from the valvular endocardium. The aortic valve (29%), mitral valve (25%), tricuspid valve (17%) and pulmonary valves (13%) are involved in that order [1]. However, PFE arising from semilunar valves are located with equal frequencies on the ventricular and arterial sides of the valves. In addition, non-valvular origin was observed in approximately 16% cases that included left and right ventricular septal and mural endocardial surfaces, atrial endocardium, papillary muscles, chordae tendinae or intima of the right coronary ostium [110]. In addition, multifocal "tepete" (carpet-like) PFE of the left ventricular cavity has also been reported [2].
The origin of PFE is unclear and various possible causes have been mentioned in the literature. They have been considered as hamartomas, organized thrombi, iatrogenic (post radiation, surgery) or inflammatory foci due to unusual endocardial responses to infection or hemodynamic trauma [3]. However, some authors believe that PFE's are true neoplasms [13].
Clinical presentation of PFE's varies from asymptomatic to severe thromboembolic complications, myocardial ischemia, infarction and stroke. However, pulmonary embolism, congestive heart failure, near-syncope, ventricular fibrillation and sudden death have also been reported [110]. Embolisation may occur from fragments of the fronds of the tumour or from a thrombus that frequently forms on the tumour 'nidus' due to platelet or fibrin aggregates.
In our patient, the atypical vague chest discomfort and pain could have been due to the partial, intermittent obstruction or limitation of blood flow through the right coronary artery orifice in the aortic root due to the strategic location and variable mobility of the tumour mass during various phases of cardiac cycle (Figure 2 and 3). Therefore, this could be considered as angina-like symptom.
The diagnosis is usually made by 2-dimentional or transoesophageal echocardiography. Recently, 3-D echocardiography, magnetic resonance imaging and multislice spiral computed tomography have also been used for better delineation of similar tumors [6, 8]. Typical echocardiographic features include a small (1-4 cm), highly mobile mass with a pedicle attached to the valve or endocardial surface and a frond-like appearance with or without multifocal involvement. The contrast CT image typically shows a filling defect in the aortic root adjacent to the origin of coronary artery [6].
Despite the benign nature of this tumour, it carries very high risk of embolic complications including neurological deficit. The fragile nature and frond-like papillary tissues of the tumour itself is prone to thromboembolism [17]. Therefore, once diagnosed, urgent surgical management is indicated even in the asymptomatic patients [1, 4, 5, 7, 10]. The management of such tumours also includes early anticoagulation. The surgical management requires extracorporeal circulation and an aortotomy which is similar to that used in typical aortic valve replacement procedures. The PFE's are usually pedunculated and may be easily removed with associated endocardial tissue. Care should be taken to avoid fragmentation of the tumour tissue. Also, aortic valve should be preserved preferably. In case, if there is resultant valve defect, it should be repaired, otherwise a valve replacement is warranted. The surgical resection is curative, safe and well tolerated [5, 7, 9, 10]. Intraoperative TEE is essential to assess valvular function after tumour resection. Re-growth of the tumour after resection has not been reported, and it requires long-term TEE follow-up studies to confirm.
Law 'et al' have done a review of the English language literature using 'Pub Med' (US National Library of Medicine) to identify previously published cases of PFE from 1997 up to 2008 [2, 7]. They found 833 cases published so far with a male preponderance (58%) and mean age of 56 years. The tumour size ranged from 2 to 70 mm. The two most preferred locations were aortic (44-52%) and mitral valve (35-40%). In majority of the cases echocardiography was the imaging modality (98%) and excision of the tumour (79%) as preferred treatment. We have tried to update the review of literature including recently published reports (Table 1).
Table 1
Previously reported cases of cardiac papillary fibroelastoma
Reference
Number of patient
Mean age (yr)
Sex distribution
Size (mm)
Site
Presentation
Management
Grinda 'et al' 1
(1999)
04
54
3 Males 1 Female
10
1 MV
1 TV
1 AV
CVA
Aphasia
Syncope
TIA
Excision+MVR
Excision+TVR
Excision+AVRp
Excision
Saw 'et al' 14
(2001)
03
45
2 Females
6-7
1 IVS
2 MV
Stroke
Abdominal pain, VSD
Excision
Darvishian 'et al' 7
(2001)
02
50
1 Male
10-15
2 MV
Dyspnea
Ataxia
Dysphasia
Mitral
Repair+ excision
Gowda 'et al' 13
(2003)
725
70
56% Males
2-70
44% AV
35% MV
32% Stroke
13% Angina
81% Excision
10% AVR
Sato 'et al' 9
(2003)
01
74
Male
9
LVOT
AF
Chest discomfort
Excision
Ngaage 'et al' 12
(2005)
88
62
71% Males
-
52% AV
18%- LVOT
52% -Dyspnea
32% TE
83% excision
Kumbala 'et al' 11
(2008)
01
60
Male
9
AV
TIA
Excision
Law' et al' 2
(2009)
01
25
Male
9
LVOT (multiple)
Stroke
Excision+MVRp
Bicer 'et al' 3
(2009)
01
72
Male
12
LA
Stroke
Excision
Parthenakis 'et al' 8
(2009)
01
29
Female
12
AV
Asymptomatic
Excision
Domenech 'et al' 4
(2010)
01
59
Female
11
LV
Stroke
Resection
AV-aortic valve, IVS-interventricular septum, MV-mitral valve, CVA-cerebrovascular accident, TIA-transient ischemic attack, VSD-ventricular septal defect, AF- atrial fibrillation, LVOT-left ventricular outflow tract, LA- left atrium, LV- left ventricle, MVR-mitral valve repair, TVR-tricuspid valve repair, AVRp-aortic valve replacement, MVRp-mitral valve replacement, AVR-aortic valve repair

Conclusion

Cardiac PFE's are not uncommon tumours and should be considered in the differential diagnosis of cardiac masses. A strong suspicion, appropriate use of imaging modality, pre operative anticoagulation and urgent resection of the tumour is not only life saving but also avoids tumour-related vascular, embolic or neurological complications.
Written informed consent was obtained from the patient for publication of this case report and any accompanying image. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

All authors have contributed in case management, manuscript preparation and image acquisition.
Literatur
1.
Zurück zum Zitat Grinda JM, Couetil JP, Chauvaud S, D'Attellis N, Berrebi A, Fabiani JN, Deloche A, Carpentier A: Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg. 1999, 117: 106-10. 10.1016/S0022-5223(99)70474-5.CrossRefPubMed Grinda JM, Couetil JP, Chauvaud S, D'Attellis N, Berrebi A, Fabiani JN, Deloche A, Carpentier A: Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg. 1999, 117: 106-10. 10.1016/S0022-5223(99)70474-5.CrossRefPubMed
2.
Zurück zum Zitat Law KB, Phillips KRB, Cusimano RJ, Butany J: Multifocal " tapete" papillary fibroelastoma. J Clin Pathol. 2009, 62: 1066-1070. 10.1136/jcp.2009.070243.CrossRefPubMed Law KB, Phillips KRB, Cusimano RJ, Butany J: Multifocal " tapete" papillary fibroelastoma. J Clin Pathol. 2009, 62: 1066-1070. 10.1136/jcp.2009.070243.CrossRefPubMed
3.
Zurück zum Zitat Bicer M, Cikirikcioglu M, Pektok E, Muller H, Dettwiler S, Kalangos A: Papillary fibroelastoma of the left atrial wall: a case report. Journal of Cardiothoracic Surgery. 2009, 4: 28-10.1186/1749-8090-4-28.CrossRefPubMedPubMedCentral Bicer M, Cikirikcioglu M, Pektok E, Muller H, Dettwiler S, Kalangos A: Papillary fibroelastoma of the left atrial wall: a case report. Journal of Cardiothoracic Surgery. 2009, 4: 28-10.1186/1749-8090-4-28.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Domenech A, Arenaza DP, Rivello HG, Patrucco L, Bracco D: Surgery for papillary fibroelstoma with uncommon location in left ventricle. Asian Cardiovasc Thorac Ann. 2010, 18: 174-6.CrossRefPubMed Domenech A, Arenaza DP, Rivello HG, Patrucco L, Bracco D: Surgery for papillary fibroelstoma with uncommon location in left ventricle. Asian Cardiovasc Thorac Ann. 2010, 18: 174-6.CrossRefPubMed
6.
Zurück zum Zitat Chia PL: Incidental finding of an aortic valve mass on 64-slice computed tomographic coronary angiography. Annals Academy of Medicine. 2009, 38 (10): 926-927. Chia PL: Incidental finding of an aortic valve mass on 64-slice computed tomographic coronary angiography. Annals Academy of Medicine. 2009, 38 (10): 926-927.
7.
Zurück zum Zitat Darvishian F, Farmer P: Papillary fibroelstoma of the heart: report of two cases and review of the literature. Annals of Clinical & Laboratory Science. 2001, 31 (3): 291-296. Darvishian F, Farmer P: Papillary fibroelstoma of the heart: report of two cases and review of the literature. Annals of Clinical & Laboratory Science. 2001, 31 (3): 291-296.
8.
Zurück zum Zitat Parthenakis F, Nyktari E, Patrianakos A, Pitsis A, Asimaki A, Vardas P: Asymptomatic papillary fibroelastoma of the aortic valve in a young woman-a case report. Cardiovascular Ultrasound. 2009, 7: 43-10.1186/1476-7120-7-43.CrossRefPubMedPubMedCentral Parthenakis F, Nyktari E, Patrianakos A, Pitsis A, Asimaki A, Vardas P: Asymptomatic papillary fibroelastoma of the aortic valve in a young woman-a case report. Cardiovascular Ultrasound. 2009, 7: 43-10.1186/1476-7120-7-43.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Sato Y, Yokoyama H, Satokawa H, Takase S, Maruyama Y: A report of a surgical case of papillary fibroelastoma in the left ventricular outflow tract. Ann Thorac Cardiovasc Surg. 2003, 9 (4): 270-273.PubMed Sato Y, Yokoyama H, Satokawa H, Takase S, Maruyama Y: A report of a surgical case of papillary fibroelastoma in the left ventricular outflow tract. Ann Thorac Cardiovasc Surg. 2003, 9 (4): 270-273.PubMed
10.
Zurück zum Zitat Gopaldas RR, Atluri PV, Blaustein AS, Bakaeen FG, Huh J, Chu D: Papillary fibroelastoma of the aortic valve-operative approaches upon incidental discovery. Tex Heart Inst J. 2009, 36 (2): 160-163.PubMedPubMedCentral Gopaldas RR, Atluri PV, Blaustein AS, Bakaeen FG, Huh J, Chu D: Papillary fibroelastoma of the aortic valve-operative approaches upon incidental discovery. Tex Heart Inst J. 2009, 36 (2): 160-163.PubMedPubMedCentral
11.
Zurück zum Zitat Kumbala D, Sharp T, Kamalesh M: "Perilous Pearl" papillary fibroelastoma of aortic valve: a case report and literature review. Angiology. 2008, 59 (5): 625-628. 10.1177/0003319707305986.CrossRefPubMed Kumbala D, Sharp T, Kamalesh M: "Perilous Pearl" papillary fibroelastoma of aortic valve: a case report and literature review. Angiology. 2008, 59 (5): 625-628. 10.1177/0003319707305986.CrossRefPubMed
12.
Zurück zum Zitat Ngaage DL, Mullany CJ, Daly RC, Dearani JA, Edwards WD, Tazelaar HD, Mcgregor CGA: Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. Ann Thorac Surg. 2005, 80: 712-18. 10.1016/j.athoracsur.2005.04.080.CrossRef Ngaage DL, Mullany CJ, Daly RC, Dearani JA, Edwards WD, Tazelaar HD, Mcgregor CGA: Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. Ann Thorac Surg. 2005, 80: 712-18. 10.1016/j.athoracsur.2005.04.080.CrossRef
13.
Zurück zum Zitat Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BG, Sacchi TJ: Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003, 146: 404-10. 10.1016/S0002-8703(03)00249-7.CrossRefPubMed Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BG, Sacchi TJ: Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003, 146: 404-10. 10.1016/S0002-8703(03)00249-7.CrossRefPubMed
14.
Zurück zum Zitat Saw W, Nicholls S, Trim G, Thomson D, Hughes C, Mitchell S, Leitch J: Papillary fibroelastoma, a rare but potentially treatable cause of embolic stroke: report of three cases. Heart, Lung and Circulation. 2001, 10 (2): 105-7. 10.1046/j.1444-2892.2001.00082.x.CrossRefPubMed Saw W, Nicholls S, Trim G, Thomson D, Hughes C, Mitchell S, Leitch J: Papillary fibroelastoma, a rare but potentially treatable cause of embolic stroke: report of three cases. Heart, Lung and Circulation. 2001, 10 (2): 105-7. 10.1046/j.1444-2892.2001.00082.x.CrossRefPubMed
Metadaten
Titel
Papillary fibroelastoma of the aortic valve - a case report and literature review
verfasst von
Neerod K Jha
Michael Khouri
Donogh M Murphy
Alessandro Salustri
Javed A Khan
Moataz A Saleh
Friederike Von Canal
Norbert Augustin
Publikationsdatum
01.12.2010
Verlag
BioMed Central
Erschienen in
Journal of Cardiothoracic Surgery / Ausgabe 1/2010
Elektronische ISSN: 1749-8090
DOI
https://doi.org/10.1186/1749-8090-5-84

Weitere Artikel der Ausgabe 1/2010

Journal of Cardiothoracic Surgery 1/2010 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.